Tiverton Asset Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-8,550
Closed -$216K 728
2019
Q2
$216K Sell
8,550
-5,695
-40% -$153K 0.01% 554
2019
Q1
$387K Sell
14,245
-91,612
-87% -$3.07M 0.02% 413
2018
Q4
$3.49M Sell
105,857
-43,009
-29% -$1.73M 0.21% 98
2018
Q3
$6.95M Sell
148,866
-56,250
-27% -$2.58M 0.34% 76
2018
Q2
$8.88M Sell
205,116
-17,200
-8% -$824K 0.45% 59
2018
Q1
$12.4M Sell
222,316
-148,715
-40% -$8.15M 0.86% 32
2017
Q4
$19.8M Sell
371,031
-80,308
-18% -$3.79M 1.24% 15
2017
Q3
$19.5M Sell
451,339
-18,804
-4% -$894K 1.1% 19
2017
Q2
$28.4M Sell
470,143
-56,067
-11% -$3.32M 1.53% 13
2017
Q1
$36.5M Sell
526,210
-35,795
-6% -$2.49M 1.87% 9
2016
Q4
$37.5M Buy
+562,005
New +$36.6M 2.22% 4

Other funds holding MD

Tiverton Asset Management's MD Position: Q3 2019 in Review

Tiverton Asset Management sold out of Pediatrix Medical (MD) in Q3 2019, closing a stake of 8,550 shares — an estimated $216K sold.

Tiverton Asset Management first reported a position in MD in Q4 2016 and held it in 11 quarters. The position peaked at $37.5M in Q4 2016. 223 funds tracked by Wall St. Rank hold MD as of Q3 2019.

  • Tiverton Asset Management reported no remaining Pediatrix Medical position as of Q3 2019 after selling out during the quarter.
  • Tiverton Asset Management sold 8,550 Pediatrix Medical shares in Q3 2019, an estimated $216K.
  • Tiverton Asset Management first reported a position in Pediatrix Medical in Q4 2016 and held it in 11 quarters.
  • Tiverton Asset Management's Pediatrix Medical position peaked at $37.5M in Q4 2016.
  • 223 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.